Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Jan 16, 2022; 14(1): 49-62
Published online Jan 16, 2022. doi: 10.4253/wjge.v14.i1.49
Table 2 Characteristics of treated lesions and patients, n (%)
(A) Lesions (n = 175)
Macroscopic type
Protruded type (0-I, 0-I+IIa, 0-I+IIb, 0-I+IIc)24 (13.7)
Flat type (0-IIa, 0-IIa+IIc, 0-IIb, 0-IIc, 0-IIc+IIa)150 (85.7)
Advanced (type 1)1 (0.6)
Ulceration
UL (+)22 (12.6)
UL ()153 (87.4)
Depth of invasion
M152 (86.9)
≥ SM 23 (13.1)
(B) Patients (n = 124)
Underlying disease
Circulatory38 (30.6)
Respiratory9 (7.3)
Renal0
Antithrombotic agent
Taking28 (22.6)